Brief: MedinCell To Resume Trading On Euronext Paris
Jan 7 (Reuters) - Medincell SA MEDCL.PA :
* MEDINCELL ANNOUNCES THE RESUME OF LISTING OF ITS SHARES ON
EURONEXT PARIS AS OF THE OPENING OF THE STOCK EXCHANGE TOMORROW
Source text : https://bwnews.pr/2XiLFmp
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Medincell SA
See all newsBrief: Medincell Has Secured An Additional EUR 13.8 Million In Non-Dilutive Financing From Leading European Commercial Banks And Bpifrance
Teva gains after FDA approves monthly schizophrenia injection
Corrected: UPDATE 1-Teva wins FDA approval for monthly schizophrenia injection Weltruza
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Brief: Medincell Announces Temporary Shares Trading Suspension On Euronext Paris